Cliff Asness's ORKA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 4,207 shares of Oruka Therapeutics, Inc. (ORKA) worth $206,354, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in ORKA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Oruka Therapeutics (ORKA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Oruka Therapeutics (ORKA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +4,207 | New Buy | 4,207 | $49.05 |
Cliff Asness's Oruka Therapeutics Investment FAQs
Cliff Asness first purchased Oruka Therapeutics, Inc. (ORKA) in Q1 2026, acquiring 4,207 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Oruka Therapeutics, Inc. (ORKA) for 1 quarters since Q1 2026.
Cliff Asness's largest addition to Oruka Therapeutics, Inc. (ORKA) was in Q1 2026, adding 4,207 shares worth $206,354.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 4,207 shares of Oruka Therapeutics, Inc. (ORKA), valued at approximately $206,354.
As of the Q1 2026 filing, Oruka Therapeutics, Inc. (ORKA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Oruka Therapeutics, Inc. (ORKA) was 4,207 shares, as reported at the end of Q1 2026.